Rossari Biotech (Small Cap) Share Target 2025, 2026 To 2035
|
Rossari Biotech Limited |
|||
|
Price: ₹805.30 (-1.23%) | ||
| 52 Week Low: ₹656.95 52 Week High: ₹972.70 |
|||
| Market Capital: 3,837.21 Crore (Smallcap) | |||
| Basic Materials -> Specialty Chemicals | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Rossari Biotech Share Price Target For 2025
- 1.1.1: Rossari Biotech Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Rossari Biotech Share Price Target For 2026
- 1.2.1: Rossari Biotech Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Rossari Biotech Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Rossari Biotech Brief Company Overview
- 4: Rossari Biotech Financial Performance
- 4.0.1: Is Rossari Biotech A Good Buy For Long Term?
Rossari Biotech, a Small Cap company in the Specialty Chemicals Industry has delivered 1.2% returns in 1-year showing 16.3% quarterly revenue growth with 7.1% profit margin.
To predict the Rossari Biotech's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Rossari Biotech Share Price Target For 2025
The line chart displays the monthly closing prices of Rossari Biotech with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Rossari Biotech shares in 2025, see the table below.
Rossari Biotech Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 873.0 (+8.4%) | Price Action: 13 Aug 2024 Low |
| 2025 Target 2 | 863.4 (+7.21%) | Price Action: Feb 2021 Low |
| 2025 Target 1 | 854.0 (+6.04%) | Price Action: Nov 2024 High |
| Current Price | 805.30 | Rossari Biotech's share price as of 17 Jan 2025 |
| Stop Loss 1 | 783.7 (-2.69%) | Price Action: 10 Jan 2024 Low |
| Stop Loss 2 | 775.4 (-3.72%) | Price Action: 19 Jan 2024 Low |
| Stop Loss 3 | 767.0 (-4.76%) | Price Action: 20 Feb 2024 High |
Short-Term Technical Outlook
Current Technical Position: Rossari Biotech is showing mixed momentum signals near key moving averages.
Key Technical Level: The 50-day moving average at ₹808.84 serves as the nearest technical reference point.
Historical Returns: 3-month: -0.33% | 6-month: -3.42% | 1-year: +1.17%
Rossari Biotech Share Price Target For 2026
The line chart displays the monthly closing prices of Rossari Biotech with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Rossari Biotech shares in 2026, see the table below.
Rossari Biotech Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 1109.62 (+37.78%) | Price Action: Chart |
| 2026 Target 2 | 1088.93 (+35.22%) | Fibonacci Extension Level 64.90% |
| 2026 Target 1 | 1075.84 (+33.59%) | Fibonacci Extension Level 123.60% |
| Current Price | 805.30 | Rossari Biotech's share price as of 17 Jan 2025 |
| Stop Loss 1 | 740.25 (-8.08%) | Price Action: 15 Feb 2024 Low |
| Stop Loss 2 | 732.25 (-9.08%) | Price Action: 30 Nov 2023 High |
| Stop Loss 3 | 724.9 (-9.99%) | Price Action: Jun 2023 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Rossari Biotech is currently trading at 47.0% of its 52-week range (₹656.95 - ₹972.7).
Long-Term Trend Analysis: The stock shows mixed long-term signals, trading near key moving averages.
Long-Term Performance: 1-year: +1.17% | 3-year: -32.77% | 5-year: NA
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Rossari Biotech Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹805.30 | ||
| 2025 | ₹838.66 | +4.14% | ₹851.24 |
| 2026 | ₹954.20 | +13.77% | ₹968.51 |
| 2027 | ₹999.69 | +4.76% | ₹1,014.69 |
| 2028 | ₹1,137.56 | +13.79% | ₹1,154.62 |
| 2029 | ₹1,160.52 | +2.01% | ₹1,177.93 |
| 2030 | ₹1,300.42 | +12.05% | ₹1,319.93 |
| 2031 | ₹1,401.32 | +7.75% | ₹1,422.34 |
| 2032 | ₹1,465.02 | +4.54% | ₹1,487.00 |
| 2033 | ₹1,621.80 | +10.7% | ₹1,646.13 |
| 2034 | ₹1,652.62 | +1.9% | ₹1,677.41 |
| 2035 | ₹1,842.53 | +11.49% | ₹1,870.17 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Rossari Biotech Brief Company Overview
Rossari Biotech: A Specialty Chemicals Powerhouse Rossari Biotech Limited is a prominent manufacturer of specialty chemicals catering to diverse industries in India and globally. Established in 1997, the company has earned a notable reputation within the industry. ...
Key Products and Services: Soap and detergents Inks, paints, and coatings Ceramics and tiles Pulp and papers Cement Performance additives Water treatment solutions Textile specialty chemicals Poultry nutrition products Diverse Product Range: Rossari Biotech's extensive product portfolio caters to various sectors, demonstrating their commitment to innovation and versatility.Rossari Biotech Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 3,837.21 Crore | Market valuation of Rossari Biotech's shares. |
| Revenue (TTM) | 1,830.55 Crore | Total revenue generated by Rossari Biotech over the past twelve months. |
| Net Income (TTM) | +130.68 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +10.05% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +7.13% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+16.3% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+17.8% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
11.33 | Company's total debt divided by total shareholder equity. |
| Total Debt | 118.79 Crore | Sum of Rossari Biotech's current & long-term financial obligations. |
| Total Cash | 67.79 Crore | Total amount of liquid funds available to Rossari Biotech. |
| Beta | 0.15 | Beta is less than 1 indicating that the Rossari Biotech's price is less volatile than the market. |
Is Rossari Biotech A Good Buy For Long Term?
Based on the provided data, Rossari Biotech's financial performance shows a steady revenue growth of 16.3% compared to the previous quarter and a moderate earnings growth of 17.8% against the same quarter last year. However, the company carries a debt of 118.79 Crore, which needs to be considered. Given the recent negative returns over various periods and a profit margin of 7.13%, Rossari Biotech may be considered an average buy for long-term investment, with potential growth opportunities but also some risks to be aware of.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
